Janssen Inc. v JAMP
Federal Court No. T-47-24 and T-48-24
We represented Janssen.
This action related to Janssen’s 024 Patent covering the diabetes drug INVOKANA.
The action was discontinued in April 2025.Federal Court No. T-47-24 and T-48-24
We represented Janssen.
This action related to Janssen’s 024 Patent covering the diabetes drug INVOKANA.
The action was discontinued in April 2025.
